Bardo Hassemer is a seasoned executive with extensive leadership experience in regulated life-science and healthcare environments, combining operational excellence with deep expertise in quality, risk management, and clinical development.

He has worked across leading pharmaceutical and MedTech organizations, including Boehringer Ingelheim, Roche, BioNTech, and Zeiss Meditec, supporting complex, compliance-critical operations and digital transformation initiatives.

With a strong foundation in regulatory frameworks and digital systems, Bardo specializes in translating clinical, technical, and regulatory requirements into scalable, audit-ready structures.

He brings a structured, analytical approach to governance, enabling organizations to balance agility with compliance while strengthening investor confidence and long-term resilience.

​

As a member of the SynapCon Advisory Board, Bardo provides independent oversight and strategic guidance, ensuring robust governance, regulatory alignment, and sustainable, scalable growth.